|
2024-01-24 |
2024-01-24 |
GV
Geplanter Verkauf
|
Walker Karin L
Chief Accounting Officer
Führungsperson
|
5.000
-100.0%
34,00
170.000 USD
|
5.000
-100.0%
|
34,00
|
170.000 USD
|
|
|
2023-12-20 |
2023-12-20 |
GV
Geplanter Verkauf
|
Walker Karin L
Chief Accounting Officer
Führungsperson
|
3.322
-100.0%
37,45
124.409 USD
|
3.322
-100.0%
|
37,45
|
124.409 USD
|
|
|
2023-12-20 |
2023-12-20 |
GV
Geplanter Verkauf
|
Walker Karin L
Chief Accounting Officer
Führungsperson
|
1.678
-33.6%
36,68
61.543 USD
|
1.678
-33.6%
|
36,68
|
61.543 USD
|
|
|
2023-11-30 |
2023-11-30 |
GV
Geplanter Verkauf
|
Walker Karin L
Chief Accounting Officer
Führungsperson
|
5.000
-100.0%
34,00
170.000 USD
|
5.000
-100.0%
|
34,00
|
170.000 USD
|
|
|
2023-10-25 |
2023-10-25 |
GV
Geplanter Verkauf
|
Walker Karin L
Chief Accounting Officer
Führungsperson
|
294
-100.0%
42,28
12.430 USD
|
294
-100.0%
|
42,28
|
12.430 USD
|
|
|
2023-10-25 |
2023-10-25 |
GV
Geplanter Verkauf
|
Walker Karin L
Chief Accounting Officer
Führungsperson
|
2.917
-90.8%
41,38
120.718 USD
|
2.917
-90.8%
|
41,38
|
120.718 USD
|
|
|
2023-10-25 |
2023-10-25 |
GV
Geplanter Verkauf
|
Walker Karin L
Chief Accounting Officer
Führungsperson
|
1.789
-35.8%
40,27
72.043 USD
|
1.789
-35.8%
|
40,27
|
72.043 USD
|
|
|
2023-10-11 |
2023-10-11 |
GV
Geplanter Verkauf
|
Smith Brandon S.
Chief Operating Officer
Führungsperson
|
444
-100.0%
47,74
21.198 USD
|
444
-100.0%
|
47,74
|
21.198 USD
|
|
|
2023-10-11 |
2023-10-11 |
GV
Geplanter Verkauf
|
Smith Brandon S.
Chief Operating Officer
Führungsperson
|
3.556
-88.9%
46,62
165.786 USD
|
3.556
-88.9%
|
46,62
|
165.786 USD
|
|
|
2023-10-04 |
2023-10-04 |
GV
Geplanter Verkauf
|
Karp Carol D.
Chief Regulatory Officer
Führungsperson
|
663
-100.0%
47,29
31.355 USD
|
663
-100.0%
|
47,29
|
31.355 USD
|
|
|
2023-10-04 |
2023-10-04 |
GV
Geplanter Verkauf
|
Karp Carol D.
Chief Regulatory Officer
Führungsperson
|
4.337
-86.7%
46,51
201.729 USD
|
4.337
-86.7%
|
46,51
|
201.729 USD
|
|
|
2023-09-27 |
2023-09-27 |
GV
Geplanter Verkauf
|
Malecek Michael J
Chief Legal Officer
Führungsperson
|
404
-100.0%
48,31
19.519 USD
|
404
-100.0%
|
48,31
|
19.519 USD
|
|
|
2023-09-27 |
2023-09-27 |
GV
Geplanter Verkauf
|
Malecek Michael J
Chief Legal Officer
Führungsperson
|
4.596
-91.9%
47,29
217.366 USD
|
4.596
-91.9%
|
47,29
|
217.366 USD
|
|
|
2023-09-19 |
2023-09-19 |
GV
Geplanter Verkauf
|
Walker Karin L
Chief Accounting Officer
Führungsperson
|
5.000
-100.0%
52,36
261.807 USD
|
5.000
-100.0%
|
52,36
|
261.807 USD
|
|
|
2023-09-13 |
2023-09-13 |
GV
Geplanter Verkauf
|
Smith Brandon S.
Chief Operating Officer
Führungsperson
|
114
-100.0%
55,96
6.379 USD
|
114
-100.0%
|
55,96
|
6.379 USD
|
|
|
2023-09-13 |
2023-09-13 |
GV
Geplanter Verkauf
|
Smith Brandon S.
Chief Operating Officer
Führungsperson
|
3.886
-97.2%
55,48
215.584 USD
|
3.886
-97.2%
|
55,48
|
215.584 USD
|
|
|
2023-09-13 |
2023-09-13 |
GV
Geplanter Verkauf
|
Garren Hideki
Chief Medical Officer
Führungsperson
|
2.000
-100.0%
55,48
110.952 USD
|
2.000
-100.0%
|
55,48
|
110.952 USD
|
|
|
2023-09-06 |
2023-09-06 |
GV
Geplanter Verkauf
|
Karp Carol D.
Chief Regulatory Officer
Führungsperson
|
6
-100.0%
55,27
332 USD
|
6
-100.0%
|
55,27
|
332 USD
|
|
|
2023-09-06 |
2023-09-06 |
GV
Geplanter Verkauf
|
Karp Carol D.
Chief Regulatory Officer
Führungsperson
|
4.994
-99.9%
54,76
273.472 USD
|
4.994
-99.9%
|
54,76
|
273.472 USD
|
|
|
2023-08-30 |
2023-08-30 |
GV
Geplanter Verkauf
|
Malecek Michael J
Chief Legal Officer
Führungsperson
|
14
-100.0%
56,21
787 USD
|
14
-100.0%
|
56,21
|
787 USD
|
|
|
2023-08-30 |
2023-08-30 |
GV
Geplanter Verkauf
|
Malecek Michael J
Chief Legal Officer
Führungsperson
|
2.664
-99.5%
55,39
147.551 USD
|
2.664
-99.5%
|
55,39
|
147.551 USD
|
|
|
2023-08-30 |
2023-08-30 |
GV
Geplanter Verkauf
|
Malecek Michael J
Chief Legal Officer
Führungsperson
|
2.322
-46.4%
54,58
126.728 USD
|
2.322
-46.4%
|
54,58
|
126.728 USD
|
|
|
2023-08-18 |
2023-08-18 |
GV
Geplanter Verkauf
|
Walker Karin L
Chief Accounting Officer
Führungsperson
|
5.000
-100.0%
57,18
285.923 USD
|
5.000
-100.0%
|
57,18
|
285.923 USD
|
|
|
2023-08-16 |
2023-08-16 |
GV
Geplanter Verkauf
|
Smith Brandon S.
Chief Operating Officer
Führungsperson
|
401
-100.0%
59,91
24.025 USD
|
401
-100.0%
|
59,91
|
24.025 USD
|
|
|
2023-08-16 |
2023-08-16 |
GV
Geplanter Verkauf
|
Smith Brandon S.
Chief Operating Officer
Führungsperson
|
1.373
-77.4%
59,15
81.217 USD
|
1.373
-77.4%
|
59,15
|
81.217 USD
|
|
|
2023-08-16 |
2023-08-16 |
GV
Geplanter Verkauf
|
Smith Brandon S.
Chief Operating Officer
Führungsperson
|
2.226
-55.6%
58,22
129.602 USD
|
2.226
-55.6%
|
58,22
|
129.602 USD
|
|
|
2023-08-16 |
2023-08-16 |
GV
Geplanter Verkauf
|
Garren Hideki
Chief Medical Officer
Führungsperson
|
374
-100.0%
59,74
22.341 USD
|
374
-100.0%
|
59,74
|
22.341 USD
|
|
|
2023-08-16 |
2023-08-16 |
GV
Geplanter Verkauf
|
Garren Hideki
Chief Medical Officer
Führungsperson
|
748
-66.7%
58,93
44.079 USD
|
748
-66.7%
|
58,93
|
44.079 USD
|
|
|
2023-08-16 |
2023-08-16 |
GV
Geplanter Verkauf
|
Garren Hideki
Chief Medical Officer
Führungsperson
|
878
-43.9%
58,15
51.059 USD
|
878
-43.9%
|
58,15
|
51.059 USD
|
|
|
2023-08-02 |
2023-08-02 |
GV
Geplanter Verkauf
|
Karp Carol D.
Chief Regulatory Officer
Führungsperson
|
328
-100.0%
67,95
22.288 USD
|
328
-100.0%
|
67,95
|
22.288 USD
|
|
|
2023-08-02 |
2023-08-02 |
GV
Geplanter Verkauf
|
Karp Carol D.
Chief Regulatory Officer
Führungsperson
|
4.672
-93.4%
66,95
312.784 USD
|
4.672
-93.4%
|
66,95
|
312.784 USD
|
|
|
2023-08-02 |
2023-08-02 |
GV
Geplanter Verkauf
|
Zago Wagner M.
Chief Scientific Officer
Führungsperson
|
229
-100.0%
68,07
15.589 USD
|
229
-100.0%
|
68,07
|
15.589 USD
|
|
|
2023-08-02 |
2023-08-02 |
GV
Geplanter Verkauf
|
Zago Wagner M.
Chief Scientific Officer
Führungsperson
|
3.771
-94.3%
66,98
252.593 USD
|
3.771
-94.3%
|
66,98
|
252.593 USD
|
|
|
2023-07-26 |
2023-07-26 |
GV
Geplanter Verkauf
|
Malecek Michael J
Chief Legal Officer
Führungsperson
|
620
-100.0%
63,40
39.309 USD
|
620
-100.0%
|
63,40
|
39.309 USD
|
|
|
2023-07-26 |
2023-07-26 |
GV
Geplanter Verkauf
|
Malecek Michael J
Chief Legal Officer
Führungsperson
|
1.903
-75.4%
62,69
119.297 USD
|
1.903
-75.4%
|
62,69
|
119.297 USD
|
|
|
2023-07-26 |
2023-07-26 |
GV
Geplanter Verkauf
|
Malecek Michael J
Chief Legal Officer
Führungsperson
|
2.477
-49.5%
61,78
153.032 USD
|
2.477
-49.5%
|
61,78
|
153.032 USD
|
|
|
2023-07-19 |
2023-07-19 |
GV
Geplanter Verkauf
|
Walker Karin L
Chief Accounting Officer
Führungsperson
|
1.034
-100.0%
70,08
72.459 USD
|
1.034
-100.0%
|
70,08
|
72.459 USD
|
|
|
2023-07-19 |
2023-07-19 |
GV
Geplanter Verkauf
|
Walker Karin L
Chief Accounting Officer
Führungsperson
|
3.966
-79.3%
68,96
273.484 USD
|
3.966
-79.3%
|
68,96
|
273.484 USD
|
|
|
2023-07-12 |
2023-07-12 |
GV
Geplanter Verkauf
|
Smith Brandon S.
Chief Operating Officer
Führungsperson
|
800
-100.0%
67,95
54.358 USD
|
800
-100.0%
|
67,95
|
54.358 USD
|
|
|
2023-07-12 |
2023-07-12 |
GV
Geplanter Verkauf
|
Smith Brandon S.
Chief Operating Officer
Führungsperson
|
3.200
-80.0%
67,40
215.667 USD
|
3.200
-80.0%
|
67,40
|
215.667 USD
|
|
|
2023-07-12 |
2023-07-12 |
GV
Geplanter Verkauf
|
Garren Hideki
Chief Medical Officer
Führungsperson
|
92
-100.0%
68,20
6.274 USD
|
92
-100.0%
|
68,20
|
6.274 USD
|
|
|
2023-07-12 |
2023-07-12 |
GV
Geplanter Verkauf
|
Garren Hideki
Chief Medical Officer
Führungsperson
|
1.908
-95.4%
67,48
128.753 USD
|
1.908
-95.4%
|
67,48
|
128.753 USD
|
|
|
2023-07-05 |
2023-07-05 |
GV
Geplanter Verkauf
|
Karp Carol D.
Chief Regulatory Officer
Führungsperson
|
1.034
-100.0%
68,69
71.027 USD
|
1.034
-100.0%
|
68,69
|
71.027 USD
|
|
|
2023-07-05 |
2023-07-05 |
GV
Geplanter Verkauf
|
Karp Carol D.
Chief Regulatory Officer
Führungsperson
|
3.966
-79.3%
67,98
269.609 USD
|
3.966
-79.3%
|
67,98
|
269.609 USD
|
|
|
2023-07-05 |
2023-07-05 |
GV
Geplanter Verkauf
|
Zago Wagner M.
Chief Scientific Officer
Führungsperson
|
1.009
-100.0%
68,69
69.306 USD
|
1.009
-100.0%
|
68,69
|
69.306 USD
|
|
|
2023-07-05 |
2023-07-05 |
GV
Geplanter Verkauf
|
Zago Wagner M.
Chief Scientific Officer
Führungsperson
|
2.991
-74.8%
67,98
203.342 USD
|
2.991
-74.8%
|
67,98
|
203.342 USD
|
|
|
2023-07-03 |
2023-07-03 |
GV
Geplanter Verkauf
|
Selkoe Dennis J.
Nicht geschäftsführender Verwaltungsratsmitglied
|
5.000
-63.7%
67,43
337.150 USD
|
5.000
-63.7%
|
67,43
|
337.150 USD
|
|
|
2023-06-28 |
2023-06-28 |
GV
Geplanter Verkauf
|
Malecek Michael J
Chief Legal Officer
Führungsperson
|
710
-100.0%
70,84
50.295 USD
|
710
-100.0%
|
70,84
|
50.295 USD
|
|
|
2023-06-28 |
2023-06-28 |
GV
Geplanter Verkauf
|
Malecek Michael J
Chief Legal Officer
Führungsperson
|
3.050
-81.1%
69,89
213.178 USD
|
3.050
-81.1%
|
69,89
|
213.178 USD
|
|
|
2023-06-28 |
2023-06-28 |
GV
Geplanter Verkauf
|
Malecek Michael J
Chief Legal Officer
Führungsperson
|
1.240
-24.8%
69,07
85.644 USD
|
1.240
-24.8%
|
69,07
|
85.644 USD
|
|
|
2023-06-20 |
2023-06-20 |
GV
Geplanter Verkauf
|
Walker Karin L
Chief Accounting Officer
Führungsperson
|
529
-100.0%
69,99
37.027 USD
|
529
-100.0%
|
69,99
|
37.027 USD
|
|
|
2023-06-20 |
2023-06-20 |
GV
Geplanter Verkauf
|
Walker Karin L
Chief Accounting Officer
Führungsperson
|
2.471
-82.4%
69,49
171.699 USD
|
2.471
-82.4%
|
69,49
|
171.699 USD
|
|
|
2023-06-20 |
2023-06-20 |
GV
Geplanter Verkauf
|
Walker Karin L
Chief Accounting Officer
Führungsperson
|
2.000
-40.0%
67,88
135.768 USD
|
2.000
-40.0%
|
67,88
|
135.768 USD
|
|
|
2023-06-16 |
2023-06-16 |
GV
Geplanter Verkauf
|
Garren Hideki
Chief Medical Officer
Führungsperson
|
7.331
-100.0%
74,00
542.494 USD
|
7.331
-100.0%
|
74,00
|
542.494 USD
|
|
|
2023-06-14 |
2023-06-14 |
GV
Geplanter Verkauf
|
Garren Hideki
Chief Medical Officer
Führungsperson
|
655
-100.0%
75,49
49.443 USD
|
655
-100.0%
|
75,49
|
49.443 USD
|
|
|
2023-06-14 |
2023-06-14 |
GV
Geplanter Verkauf
|
Garren Hideki
Chief Medical Officer
Führungsperson
|
2.534
-79.5%
74,59
189.010 USD
|
2.534
-79.5%
|
74,59
|
189.010 USD
|
|
|
2023-06-14 |
2023-06-14 |
GV
Geplanter Verkauf
|
Garren Hideki
Chief Medical Officer
Führungsperson
|
971
-23.3%
73,31
71.184 USD
|
971
-23.3%
|
73,31
|
71.184 USD
|
|
|
2023-06-14 |
2023-06-14 |
GV
Geplanter Verkauf
|
Garren Hideki
Chief Medical Officer
Führungsperson
|
509
-10.9%
72,45
36.879 USD
|
509
-10.9%
|
72,45
|
36.879 USD
|
|
|
2023-06-14 |
2023-06-14 |
GV
Geplanter Verkauf
|
Smith Brandon S.
Chief Operating Officer
Führungsperson
|
1.362
-100.0%
75,56
102.910 USD
|
1.362
-100.0%
|
75,56
|
102.910 USD
|
|
|
2023-06-14 |
2023-06-14 |
GV
Geplanter Verkauf
|
Smith Brandon S.
Chief Operating Officer
Führungsperson
|
959
-41.3%
74,69
71.624 USD
|
959
-41.3%
|
74,69
|
71.624 USD
|
|
|
2023-06-14 |
2023-06-14 |
GV
Geplanter Verkauf
|
Smith Brandon S.
Chief Operating Officer
Führungsperson
|
1.914
-45.2%
73,35
140.400 USD
|
1.914
-45.2%
|
73,35
|
140.400 USD
|
|
|
2023-06-14 |
2023-06-14 |
GV
Geplanter Verkauf
|
Smith Brandon S.
Chief Operating Officer
Führungsperson
|
1.098
-20.6%
72,52
79.628 USD
|
1.098
-20.6%
|
72,52
|
79.628 USD
|
|
|
2023-06-07 |
2023-06-07 |
GV
Geplanter Verkauf
|
Karp Carol D.
Chief Regulatory Officer
Führungsperson
|
361
-100.0%
72,93
26.328 USD
|
361
-100.0%
|
72,93
|
26.328 USD
|
|
|
2023-06-07 |
2023-06-07 |
GV
Geplanter Verkauf
|
Karp Carol D.
Chief Regulatory Officer
Führungsperson
|
3.811
-91.3%
71,97
274.271 USD
|
3.811
-91.3%
|
71,97
|
274.271 USD
|
|
|
2023-06-07 |
2023-06-07 |
GV
Geplanter Verkauf
|
Karp Carol D.
Chief Regulatory Officer
Führungsperson
|
12.782
-75.4%
71,00
907.495 USD
|
12.782
-75.4%
|
71,00
|
907.495 USD
|
|
|
2023-06-07 |
2023-06-07 |
GV
Geplanter Verkauf
|
Karp Carol D.
Chief Regulatory Officer
Führungsperson
|
3.046
-15.2%
69,90
212.916 USD
|
3.046
-15.2%
|
69,90
|
212.916 USD
|
|
|
2023-06-07 |
2023-06-07 |
GV
Geplanter Verkauf
|
Zago Wagner M.
Chief Scientific Officer
Führungsperson
|
294
-100.0%
73,14
21.503 USD
|
294
-100.0%
|
73,14
|
21.503 USD
|
|
|
2023-06-07 |
2023-06-07 |
GV
Geplanter Verkauf
|
Zago Wagner M.
Chief Scientific Officer
Führungsperson
|
3.759
-92.7%
71,96
270.479 USD
|
3.759
-92.7%
|
71,96
|
270.479 USD
|
|
|
2023-06-07 |
2023-06-07 |
GV
Geplanter Verkauf
|
Zago Wagner M.
Chief Scientific Officer
Führungsperson
|
12.004
-74.8%
70,99
852.181 USD
|
12.004
-74.8%
|
70,99
|
852.181 USD
|
|
|
2023-06-07 |
2023-06-07 |
GV
Geplanter Verkauf
|
Zago Wagner M.
Chief Scientific Officer
Führungsperson
|
2.943
-15.5%
70,02
206.061 USD
|
2.943
-15.5%
|
70,02
|
206.061 USD
|
|
|
2023-05-31 |
2023-05-31 |
GV
Geplanter Verkauf
|
Malecek Michael J
Chief Legal Officer
Führungsperson
|
711
-100.0%
65,98
46.913 USD
|
711
-100.0%
|
65,98
|
46.913 USD
|
|
|
2023-05-31 |
2023-05-31 |
GV
Geplanter Verkauf
|
Malecek Michael J
Chief Legal Officer
Führungsperson
|
1.078
-60.3%
65,20
70.286 USD
|
1.078
-60.3%
|
65,20
|
70.286 USD
|
|
|
2023-05-31 |
2023-05-31 |
GV
Geplanter Verkauf
|
Malecek Michael J
Chief Legal Officer
Führungsperson
|
3.211
-64.2%
64,16
206.025 USD
|
3.211
-64.2%
|
64,16
|
206.025 USD
|
|
|
2023-05-19 |
2023-05-19 |
GV
Geplanter Verkauf
|
Walker Karin L
Chief Accounting Officer
Führungsperson
|
2.177
-100.0%
74,47
162.128 USD
|
2.177
-100.0%
|
74,47
|
162.128 USD
|
|
|
2023-05-19 |
2023-05-19 |
GV
Geplanter Verkauf
|
Walker Karin L
Chief Accounting Officer
Führungsperson
|
2.823
-56.5%
73,63
207.850 USD
|
2.823
-56.5%
|
73,63
|
207.850 USD
|
|
